Cidara Therapeutics, Inc.
DelistedCIK 1610618fmd_1GN9KX1QZV8G1KJ10M9RDWCRKMManufacturing · Biological Products, (No Diagnostic Substances)Template: Standard
Coverage: Jan 01, 2013 to Sep 30, 2025, 48 periods
Latest annual · FY2024
Millions- Total revenues
- 1
- Operating income
- (176)
- Net income
- (170)
- Free cash flow
- (177)
Latest quarter · Q3 FY2025
Millions- Total revenues
- 0
- Operating income
- (89)
- Net income
- (83)
- Free cash flow
- (41)
Bulls and bears
Loading
News summary
An AI model writes the summary on request, from this company's recent filings only, and cites each filing it uses.
AI-written
Key stats
Open AnalysisCompound annual growth
- Revenue, 3 yearsFY2021 to FY2024
- n/m
- Revenue, 5 yearsFY2019 to FY2024
- n/m
- Net income, 5 yearsFY2019 to FY2024
- n/m
Cidara Therapeutics, Inc. financials: quick answers
Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.
| Metric | FY2024 | FY2023 | Change | Source |
|---|---|---|---|---|
| Revenue | $1.3 million | $23.3 million | -94.5% | 10-K 2025-03-06 · proof |
| Operating income | -$176.1 million | -$27.1 million | 10-K 2025-03-06 · proof | |
| Net income | -$169.8 million | -$22.9 million | 10-K 2025-03-06 · proof | |
| Cash from operating activities | -$176.5 million | -$22.4 million | 10-K 2025-03-06 · proof | |
| Free cash flow | -$176.7 million | -$22.9 million | 10-K 2025-03-06 · proof | |
| Total assets | $214.8 million | $67 million | +220.4% | 10-K 2025-03-06 · proof |
| Total liabilities | $51.5 million | $75.2 million | -31.6% | 10-K 2025-03-06 · proof |
| Cash and cash equivalents | $189.8 million | $35.8 million | +430.6% | 10-K 2025-03-06 · proof |
- What was Cidara Therapeutics, Inc.'s revenue in fiscal 2024?
- Cidara Therapeutics, Inc. reported revenue of $1.3 million for fiscal 2024 (the year ended Dec 31, 2024), against $23.3 million the year before (-94.5%). Source: the 10-K filed with the SEC on Mar 6, 2025. SEC
- What was Cidara Therapeutics, Inc.'s operating income in fiscal 2024?
- Cidara Therapeutics, Inc. reported operating income of -$176.1 million for fiscal 2024 (the year ended Dec 31, 2024), against -$27.1 million the year before. Source: the 10-K filed with the SEC on Mar 6, 2025. SEC
- What was Cidara Therapeutics, Inc.'s net income in fiscal 2024?
- Cidara Therapeutics, Inc. reported net income of -$169.8 million for fiscal 2024 (the year ended Dec 31, 2024), against -$22.9 million the year before. Source: the 10-K filed with the SEC on Mar 6, 2025. SEC
- What was Cidara Therapeutics, Inc.'s cash from operating activities in fiscal 2024?
- Cidara Therapeutics, Inc. reported cash from operating activities of -$176.5 million for fiscal 2024 (the year ended Dec 31, 2024), against -$22.4 million the year before. Source: the 10-K filed with the SEC on Mar 6, 2025. SEC
- What was Cidara Therapeutics, Inc.'s free cash flow in fiscal 2024?
- Cidara Therapeutics, Inc. reported free cash flow of -$176.7 million for fiscal 2024 (the year ended Dec 31, 2024), against -$22.9 million the year before. Source: the 10-K filed with the SEC on Mar 6, 2025. SEC
- What are Cidara Therapeutics, Inc.'s total assets?
- As of Dec 31, 2024, Cidara Therapeutics, Inc. reported total assets of $214.8 million, against $67 million a year earlier (+220.4%). Source: the 10-K filed with the SEC on Mar 6, 2025. SEC
- What are Cidara Therapeutics, Inc.'s total liabilities?
- As of Dec 31, 2024, Cidara Therapeutics, Inc. reported total liabilities of $51.5 million, against $75.2 million a year earlier (-31.6%). Source: the 10-K filed with the SEC on Mar 6, 2025. SEC
- What are Cidara Therapeutics, Inc.'s cash and cash equivalents?
- As of Dec 31, 2024, Cidara Therapeutics, Inc. reported cash and cash equivalents of $189.8 million, against $35.8 million a year earlier (+430.6%). Source: the 10-K filed with the SEC on Mar 6, 2025. SEC
Read from the FinancialMD API on Nov 14, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.
The same numbers for an agent, with proof on every value:
curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=cik:1610618&period_type=annual&limit=5"Information only, not investment advice.